It may be that the ability to raise additional capital in the biotech space is not as fortuitous this week as it was a couple of weeks ago. Those with positive cash flow recovered first, followed by those with longer runways. We'll get there if the recovery continues; just a little later
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.